Research article · 14 Apr 2026
Conference abstractPublished 26 Sep 2017
A novel small-molecule inhibitor of influenza A virus that acts by disrupting PB2 cap-binding of the viral polymerase
The University of Hong Kong, Hong Kong
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The conserved residues 318-483 in PB2 subunit (PB2cap) of influenza A polymerase is an independently folded cap-binding domain that exhibits a distinct binding mode from the cap-binding proteins of host cells, thus it is conceived to be a potential target for the development of new antiviral drugs. We developed an innovative fluorescence polarization assay to identify small-molecule inhibitors that specifically disrupted the interaction between a cap analog (m7GTP) and PB2cap. Selected compounds were tested in vitro and in vivo for antiviral efficacy. Of these, the best compound PB2-19 was identified as a potent inhibitor against the replication of multiple subtypes of influenza A virus, including H1N1, H3N2, H5N1, H7N7, H7N9 and H9N2, in Madin-Darby canine kidney cell cultures. Combinational treatment of zanamivir and PB2-19 exerted synergistic anti-influenza effect in vitro. Intranasal administration of PB2-19 enhanced survival rate and reduced lung viral loads in BALB/c mice challenged with lethal dose of H1N1 virus. Docking analyses predicted the compound interacted with the PB2 cap-binding pocket in a similar manner as m7GTP, suggesting its role as a cap-binding competitor. Our study provides new insights for the development of a new category of influenza therapeutic agents that directly target to PB2 cap-binding domain.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Infectious Diseases & Therapy.
Research article · 5 May 2025
The Ultimate Cure for the COVID Syndemic
Mini review · 29 Apr 2025
COVID-19 Systematic Mini-Review as of April 2025
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Diseases & Therapy
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Yuan Shuofeng”
